| 1 |
35285843 | Design of a novel Pt(II) complex to reverse cisplatin-induced resistance in lung cancer via a multi-mechanism. | 2022 Mar 29 |
1 |
| 2 |
35330134 | Interaction Analysis of MRP1 with Anticancer Drugs Used in Ovarian Cancer: In Silico Approach. | 2022 Mar 7 |
2 |
| 3 |
34029775 | Novel Pt(IV) complexes to overcome multidrug resistance in gastric cancer by targeting P-glycoprotein. | 2021 Oct 5 |
1 |
| 4 |
34161330 | CHD4 regulates platinum sensitivity through MDR1 expression in ovarian cancer: A potential role of CHD4 inhibition as a combination therapy with platinum agents. | 2021 |
1 |
| 5 |
32528530 | MDR1 Gene Polymorphisms and Its Association With Expression as a Clinical Relevance in Terms of Response to Chemotherapy and Prognosis in Ovarian Cancer. | 2020 |
1 |
| 6 |
30796464 | ABCB1 c.3435C>T polymorphism is associated with platinum toxicity: a preliminary study. | 2019 Apr |
2 |
| 7 |
29861877 | SNPs in predicting clinical efficacy and toxicity of chemotherapy: walking through the quicksand. | 2018 May 18 |
1 |
| 8 |
26693899 | Genetic heterogeneity after first-line chemotherapy in high-grade serous ovarian cancer. | 2016 Jan |
1 |
| 9 |
27590272 | Associations of genetic polymorphisms of the transporters organic cation transporter 2 (OCT2), multidrug and toxin extrusion 1 (MATE1), and ATP-binding cassette subfamily C member 2 (ABCC2) with platinum-based chemotherapy response and toxicity in non-small cell lung cancer patients. | 2016 Sep 2 |
1 |
| 10 |
27748801 | Acquisition of anticancer drug resistance is partially associated with cancer stemness in human colon cancer cells. | 2016 Dec |
2 |
| 11 |
27812204 | Prognostic Value and Implication for Chemotherapy Treatment of ABCB1 in Epithelial Ovarian Cancer: A Meta-Analysis. | 2016 |
1 |
| 12 |
25253429 | MDR1 and cytochrome P450 gene-expression profiles as markers of chemosensitivity in human chronic myelogenous leukemia cells treated with cisplatin and Ru(III) metallocomplexes. | 2015 Feb |
1 |
| 13 |
26288241 | Association of MDR1 gene (C3435T) polymorphism and gene expression profiling in lung cancer patients treated with platinum-based chemotherapy. | 2015 Oct |
1 |
| 14 |
24781824 | The ruthenium complexes cis-(dichloro)tetramineruthenium(III) chloride and cis-tetraammine(oxalato)ruthenium(III) dithionate overcome resistance inducing apoptosis on human lung carcinoma cells (A549). | 2014 Jun |
1 |
| 15 |
22833464 | Phase 2 trial of combined cisplatin, etoposide, gemcitabine, and methylprednisolone (PEGS) in peripheral T-cell non-Hodgkin lymphoma: Southwest Oncology Group Study S0350. | 2013 Jan 15 |
1 |
| 16 |
24687344 | MDR1 (ABCB1) polymorphisms: functional effects and clinical implications. | 2013 Sep-Oct |
1 |
| 17 |
22112610 | Common variants in ABCB1, ABCC2 and ABCG2 genes and clinical outcomes among women with advanced stage ovarian cancer treated with platinum and taxane-based chemotherapy: a Gynecologic Oncology Group study. | 2012 Mar |
1 |
| 18 |
22704851 | Role of ABCB1 C3435T in platinum-based therapy. | 2012 May |
1 |
| 19 |
22761669 | Meta-analysis on pharmacogenetics of platinum-based chemotherapy in non small cell lung cancer (NSCLC) patients. | 2012 |
1 |
| 20 |
22766400 | MDR1 single nucleotide polymorphism C3435T in Turkish patients with non-small-cell lung cancer. | 2012 Sep 15 |
1 |
| 21 |
22932088 | A meta-analytic review of ERCC1/MDR1 polymorphism and chemosensitivity to platinum in patients with advanced non-small cell lung cancer. | 2012 Aug |
2 |
| 22 |
21827803 | Polymorphisms of ERCC1 C118T/C8092A and MDR1 C3435T predict outcome of platinum-based chemotherapies in advanced non-small cell lung cancer: a meta-analysis. | 2011 Jul |
2 |
| 23 |
22296372 | Influence of MDR1 gene codon 3435 polymorphisms on outcome of platinum-based chemotherapy for advanced non small cell lung cancer. | 2011 |
5 |
| 24 |
20189873 | Association of MDR1 and ERCC1 polymorphisms with response and toxicity to cisplatin-based chemotherapy in non-small-cell lung cancer patients. | 2010 Mar |
1 |
| 25 |
19516889 | The reversal effect of magnetic Fe3O4 nanoparticles loaded with cisplatin on SKOV3/DDP ovarian carcinoma cells. | 2009 |
2 |
| 26 |
18281754 | [Predictive markers for platinum-based chemotherapy]. | 2008 Feb |
1 |
| 27 |
17686239 | [The predictive factors for the response to platinum/paclitaxel based first-line adjuvant chemotherapy in advanced ovarian cancer]. | 2007 May 8 |
1 |
| 28 |
16785472 | Genetic variations in radiation and chemotherapy drug action pathways predict clinical outcomes in esophageal cancer. | 2006 Aug 10 |
1 |
| 29 |
11878288 | Drug resistance in epithelial ovarian cancer: P-glycoprotein and glutation S-transferase. Can they play an important role in detecting response to platinum-based chemotherapy as a first-line therapy. | 2001 |
1 |
| 30 |
11809106 | [The expression of multiple drug resistance associated genes in ovarian cancer]. | 2000 Feb |
1 |